Related Experiment Video
Updated: Aug 18, 2026

Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice
Published on: June 28, 2021
Role of antibiotics in acute pancreatitis: A meta-analysis
1Department of Surgery, New York Flushing Hospital, Flushing, New York 11355, USA.
Abstract:
In an attempt to decrease the infectious complications of acute pancreatitis and its high mortality, many investigators have conducted randomized prospective trials on the efficacy of prophylactic antibiotics. The results of these studies are conflicting, and many have called for a large multicenter study. Because multicenter trials are costly and difficult to organize, we believe that meta-analysis is a reasonable alternative. A meta- analysis of all eight previously published trials of prophylactic antibiotics in acute pancreatitis was performed. The end point was death. The Mantel-Haenszel statistic was used to summarize odds ratios across studies in a fixed effects model, after homogeneity was assessed. Sensitivity analysis was performed as appropriate. The meta-analysis of all eight trials showed a positive benefit for antibiotics in reducing mortality. Sensitivity analysis showed that the advantage was limited to patients with severe pancreatitis who received broad- spectrum antibiotics that achieve therapeutic pancreatic tissue levels. It is recommended that all patients with severe pancreatitis be treated with broad- spectrum antibiotics that achieve therapeutic levels in pancreatic tissue.
Insights
Prophylactic antibiotics may reduce mortality in acute pancreatitis, particularly severe cases. Broad-spectrum antibiotics achieving therapeutic pancreatic tissue levels show the most benefit in reducing deaths from this condition.
Area of Science:
- Gastroenterology
- Infectious Diseases
- Clinical Trials
Background:
- Acute pancreatitis is associated with significant infectious complications and high mortality rates.
- Previous randomized trials on prophylactic antibiotics have yielded conflicting results.
- The need for large, multicenter studies is recognized, but their feasibility is challenging.
Purpose of the Study:
- To evaluate the efficacy of prophylactic antibiotics in reducing mortality in acute pancreatitis.
- To synthesize evidence from existing randomized prospective trials through meta-analysis.
- To identify specific patient subgroups or antibiotic regimens that demonstrate a benefit.
Main Methods:
- A meta-analysis was conducted on eight previously published randomized prospective trials.
- The primary endpoint for the meta-analysis was mortality.
- The Mantel-Haenszel statistic within a fixed effects model was used to summarize odds ratios, with homogeneity and sensitivity analyses performed.
Main Results:
- The overall meta-analysis of eight trials indicated a positive benefit of prophylactic antibiotics in reducing mortality.
- Sensitivity analysis revealed that this survival advantage was primarily observed in patients with severe acute pancreatitis.
- The benefit was specifically linked to the use of broad-spectrum antibiotics that achieve therapeutic levels within pancreatic tissue.
Conclusions:
- Prophylactic antibiotics can be beneficial in reducing mortality in acute pancreatitis.
- Treatment recommendations should focus on severe pancreatitis cases.
- Broad-spectrum antibiotics achieving adequate pancreatic tissue concentrations are crucial for achieving a survival benefit.
Related Concept Videos
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Acute Pancreatitis II: Clinical Manifestations and Management
Chronic Pancreatitis II: Collaborative Care
Assessment:
Acute Pancreatitis I: Introduction
Acute Pancreatitis II: Pathophysiology
Chronic Pancreatitis II: Pathophysiology

